Skyrizi

List of products in the National Drug Code with proprietary name skyrizi. This medication is used to treat plaque psoriasis. Risankizumab-rzaa belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural protein in your body (interleukin-23) that may cause inflammation and swelling.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Product Type
0074-1050	Skyrizi	Risankizumab-rzaa	Injection	Subcutaneous	Abbvie Inc.	Human Prescription Drug
0074-1065	Skyrizi	Risankizumab-rzaa	Kit	Intravenous	Abbvie Inc.	Human Prescription Drug
0074-1070	Skyrizi	Risankizumab-rzaa	Kit	Intravenous	Abbvie Inc.	Human Prescription Drug
0074-2100	Skyrizi	Risankizumab-rzaa	Injection	Subcutaneous	Abbvie Inc.	Human Prescription Drug
0074-5015	Skyrizi	Risankizumab-rzaa	Injection	Intravenous	Abbvie Inc.	Human Prescription Drug
0074-7034	Skyrizi	Risankizumab-rzaa	Kit		Abbvie Inc.	Human Prescription Drug
0074-7036	Skyrizi	Risankizumab-rzaa	Kit		Abbvie Inc.	Human Prescription Drug
0074-7040	Skyrizi	Risankizumab-rzaa	Kit		Abbvie Inc.	Human Prescription Drug
0074-7042	Skyrizi	Risankizumab-rzaa	Kit		Abbvie Inc.	Human Prescription Drug